Kristina Burow - Director, 10%+ Owner at Neumora Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, 10%+ Owner
Stock Symbol
NMRA on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Kristina Burow since 11/21/2023

Holdings reported by Kristina Burow for Neumora Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 12.2M $146M $11.98 Jun 13, 2024 By ARCH Venture Fund X, L.P.
Common Stock 11.9M $142M $11.98 Jun 13, 2024 By ARCH Venture Fund X Overage, L.P.
Common Stock 4.13M $49.5M $11.98 Jun 13, 2024 By ARCH Venture Fund XII, L.P.
Common Stock 2.32M $27.8M $11.98 Jun 13, 2024 By ARCH Venture Fund VIII Overage, L.P.
Common Stock 1.39M $16.6M $11.98 Jun 13, 2024 By ARCH Venture Fund VII, L.P.
Common Stock 47.7K $572K $11.98 Jun 13, 2024 Direct
Stock Option (Right to Buy) 28.6K Jun 13, 2024 Direct Common Stock

Transactions reported by Kristina Burow for Neumora Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.